Riesgo cardiovascular y hemoglobina glucosilada en adultos con diabetes tipo 2 en prevención primaria
Cardiovascular risk and glycosylated hemoglobin in adults with type 2 diabetes in primary prevention
Resumen
Abstract
Bibliografía
1. Organización Mundial de la Salud. Enfermedades cardiovasculares (ECV): hechos clave. Organización Mundial de la Salud. Publicado el 11 de Junio de 2021; [Citado 28 de enero de 2021], Disponible en: https://www.who.int/en/ news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
2. Einarson, TR, Acs, A., Ludwig, C. et al. Prevalencia de la enfermedad cardiovascular en la diabetes tipo 2: una revisión sistemática de la literatura de la evidencia científica de todo el mundo en 2007-2017. Cardiovasc Diabetol 2018;17-83. doi.org/10.1186/s12933-018-0728-6
3. Rawshani et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes, New England Journal of Medicine; 2018; 379 (7); 633-644, doi. org/10.1056/NEJMoa1800256
4. Chen-Ku CH, Gonzalez-Galvez G, Vásquez M, et al. Vascular complications in patients with type 2 diabetes: prevalence and comorbidities in 6 countries of Latin America (a cohort of the discover study program). Endocr Pract. 2019;25(10):994-1002. doi:10.4158/EP-2018-0473
5. Mosenzon, O., Alguwaihes, A., Leon, JLA et al. CAPTURE: a multinational, cross‑sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol 2021(20): 154 doi.org/10.1186/ s12933-021-01344-0
6. Aguilar-Ramirez D, Alegre-Díaz J, Gnatiuc L, Ramirez-Reyes R, y cols. Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998-2004 and 2015-2019. Diabetes Care. 10 Feb 2021;dc202276. doi: 10.2337/dc20- 2276. PMID: 33568401.
7. Alegre-Díaz J, Herrington W, López-Cervantes M, Gnatiuc L, y cols. Diabetes and Cause-Specific Mortality in Mexico City. N Engl J Med. 17 Nov 2016;375(20):1961-1971. doi: 10.1056/NEJMoa1605368. PMID: 27959614
8. Nissen, Steven E. and Wolski, Kathy. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes, New England Journal of Medicine, 2007; 356 (24): 2457-2471 doi 10.1056/NEJMoa072761
9. American Diabetes Association. Introduction: Standards of Medical Care in Diabetes-2022. Diabetes Care. 1 Ene2022;45 (Supplement_1):S1-S2. doi: 10.2337/dc22-Sint. PMID: 34964812
10. Brunton S. Pathophysiology of Type 2 Diabetes: The Evolution of Our Understanding. J Fam Pract. 2016;65(4 Suppl):- supp_az_0416
11. DeFronzo, RA. Conferencia Banting: del triunvirato al ominoso octeto: un nuevo paradigma para el tratamiento de la diabetes mellitus tipo 2.Diabetes 2009; 58:773–795.
12. Pereira Domingueti C. et al. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of Diabetes and its Complications, 2016; 30(4):738-745. doi.org/10.1016/j.jdiacomp. 2015.12.018
13. Riddle M, Gerstein H, Home P. Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters. Diabetes Care 2021; 44:2212–2215. doi.org/10.2337/dci21-0030
14. Litwak L, Goh SY, Hussein Z, et al. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study A1 chieve. Diabetol Metab Synd. 2013; 5(57). doi.org/10.1186/1758-5996-5-57
15. Hahr AJ, Molitch ME. Diabetes, cardiovascular risk and nephropathy. Cardiol Clin 2010; 28:467–475
16. Marcus Lind, Henrik Imberg, Ruth L. Coleman, Olle Nerman, Rury R. Holman; Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care, 2021;44 (10): 2231–2237. doi.org/10.2337/dc20-2439
17. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-412. doi:10.1136/ bmj.321.7258.405
18. WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. Oct 2019;7(10): e1332-e1345. doi: 10.1016/S2214- 109X(19)30318-3. PMID: 31488387.
19. PAHO. Instrucciones para el uso de la calculadora. Consultado en versión electrónica. Disponible en: https://www. paho.org/cardioapp/web/#/description
20. Organización Panamericana de la Salud. Calculadora de riesgo cardiovascular. Consultado en versión electrónica, Disponible en: https://www.paho.org/es/hearts-americas/ calculadora-riesgo-cardiovascular
21. Observatorio Mexicano de Enfermedades No Transmisibles (OMENT). Sistema de información en enfermedades crónicas, México. Universidad Autónoma de Nuevo León. [Año de actualización: 2021]. [Citado 3 de junio de 2021]. Disponible en: http://www.tablerocronicassic-sinba.com/TableroSIC/ SIC
22. Zhao Y, Malik S, Budoff MJ, et al. Identification and Predictors for Cardiovascular Disease Risk Equivalents among Adults With Diabetes Mellitus [published online ahead of print, 2021 Aug 11]. Diabetes Care. 2021; 44(10):2411-2418 dc210431. doi:10.2337/dc21-0431
23. Norma Oficial Mexicana. PROY-NOM-015-SSA2-2018, Para la prevención, detección, diagnóstico, tratamiento y control de la Diabetes Mellitus [Internet]. [Año de publicación: 2018]. [Citado 9 de febrero de 2022]. Disponible en: http:// dof.gob.mx/nota_to_doc.php?codnota=5521405
24. Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7:221–30.
25. Aguilar-Ramirez D, Alegre-Díaz J, Gnatiuc L, Ramirez-Reyes R, y cols. Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998-2004 and 2015- 2019. Diabetes Care.10 Feb 2021;dc202276. doi: 10.2337/ dc20-2276. PMID: 33568401.
26. Alegre-Díaz J, Herrington W, López-Cervantes M, Gnatiuc L, y cols. Diabetes and Cause-Specific Mortality in Mexico City. N Engl J Med. 17 Nov 2016;375(20):1961-1971. doi: 10.1056/NEJMoa1605368. PMID: 27959614.
27. PAHO. Instrucciones para el uso de la calculadora. Consultado en versión electrónica. Disponible en: https://www. paho.org/cardioapp/web/#/description
- Resumen visto - 664 veces
- PDF descargado - 30 veces